REFERENCES
- Tibbling I. Epidemiology of gastrooesophageal reflux disease. Scand J Gastroenterol 1984;19 Suppl 106:14–8.
- Johnsson F, Joelsson B, Isberg P-E. Ambulatory 24 hour oesophageal pH-monitoring in the diagnosis of gastrooesophageal reflux disease. Gut 1987;28: 1187–92.
- McTavish D, Buckley MM, Heel RC. Omeprazole—an updated review of its pharmacology and therapeutic use in acid-related disorders. Drugs 1991;42:138–70.
- Young MF, Sanowski RA, Talbert GA, Harrison ME, Walker BE. Omeprazole administration as a test for gastrooesophageal reflux. Gastroenterology 1992;102:A192.
- Champion S, Richter JE, Vaegi MF, Singh S, Alexander R. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett’s esophagus. Gastroenterology 1994;107:747–54.
- Schindlbeck NE, Klauser AG, Voderholzer WA, Muller-Lissner SA. Empiric therapy for gastroesophageal reflux disease. Arch Intern Med 1995;155:1808–12.
- Shi G, Bruley des Uarannes S, Scarpignato C, Le Rhun M, Galmich J-P. Reflux related symptoms in patients with normal esophageal exposure to acid. Gut 1995;37:457–64.
- Watson RGP, Tham TCK, Johnston BT, McDougall NI. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux—the sensitive oesophagus. Gut 1997;40: 587–90.
- Johnsson F, Joelsson B. The reproducibility of ambulatory pH- monitoring. Gut 1988;29:886–9.